X
Subscription
Thank You
Thank you for your subscription
* Required fields
Life Sciences & Med Tech
company
contacts
sector
status
description

CEO: Nuno Arantes-Oliveira

nao@alfama.com.pt

sector:

Biotechnology

status:
Growth
description:

Alfama is a world-leader in the development of carbon monoxide-releasing molecules (CO-RMs) as pharmaceutical agents, controlling most of the relevant IP in the field. Alfama's first clinical candidate will become the standard-of-care for liver injury: in addition Alfama controls a collection of about 1,000 CO_RMs, many of which have shown efficacy in a wide range of diseases and conditions.